Therapeutic receptor targets of ischemic preconditioning

Cardiovascular Research

Volumn 55, Issue 3, 2002, Pages 520-525

  Fryer, Ryan M ^a   Auchampach, John A ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adenosine; Infarction; Preconditioning; Receptors

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; ADENOSINE A1 RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ANALGESIC AGENT; ANGIOTENSIN 1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; DELTA OPIATE RECEPTOR; ENDOTHELIN RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FENTANYL; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ICATIBANT; LEVORPHANOL; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; MUSCARINIC M2 RECEPTOR; NALOXONE; OPIATE RECEPTOR; OPIATE RECEPTOR AFFECTING AGENT; PETHIDINE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RECEPTOR; ADENOSINE; ADENOSINE RECEPTOR; BRADYKININ; NARCOTIC AGENT;

ENZYME MECHANISM; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART PROTECTION; MEDIATOR; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN TARGETING; REVIEW; RISK; SIGNAL TRANSDUCTION; UNSTABLE ANGINA PECTORIS; ANIMAL; DRUG ANTAGONISM; HEART MUSCLE ISCHEMIA; HUMAN; METABOLISM;

ADENOSINE; ANIMAL; BRADYKININ; HUMAN; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; NARCOTICS; RECEPTORS, BRADYKININ; RECEPTORS, OPIOID; RECEPTORS, PURINERGIC P1; ANIMALS; HUMANS;

EID: 0036023623     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00316-4     Document Type: Review

References (59)

1. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart
2. 1 adenosine receptors in rabbit heart
3. Characterisation of the infarct-limiting effect of delayed preconditioning: Timecourse and dose-dependency studies in rabbit myocardium
4. The late phase of preconditioning
5. Adenosine receptor involvement in a delayed phase of myocardial protection 24 h after ischemic preconditioning
6. Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits
7. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms
8. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery
9. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction
10. Preconditioning of human myocardium with adenosine during coronary angioplasty
11. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial
12. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning
13. 1 receptor
14. 1 receptor activation maintains rabbit myocardium in a preconditioned state
15. 1 MF-2 cells
16. 2A-adenosine receptor reserve for coronary vasodilation
17. 1 adenosine receptor reserve for two actions of adenosine on guinea pig atrial myocytes
18. 1 adenosine receptor
19. 6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits
20. 3 receptors
21. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart
22. 3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart
23. 3 receptor activation during hypoxia in isolated rat cardiac myocytes
24. 3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning
25. 3 adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium
26. Cardiac opioids
27. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts
28. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart
29. 1- but not μ- or κ-opioid receptors
30. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits
31. Naloxone blockade of myocardial ischemic preconditioning does not require central nervous system participation
32. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart
33. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction
34. Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs
35. ATP channels
36. ATP channels
37. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATP-sensitive potassium channels
38. 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart
39. Cyclic AMP mediated arrhythmias induced in the ischaemic pig heart
40. δ-Opioid receptor stimulation mimics ischemic preconditioning in human heart muscle
41. κ- but not δ-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats
42. Phospholipase C inhibitors attenuate arrhythmias induced by κ-receptor stimulation in the isolated rat heart
43. + exchange pathway
44. Opposing effects on infarction of δ- and κ-opioid receptor activation in the isolated rat heart: Implications for ischemic preconditioning
45. ATP channels
46. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection
47. Essential activation of PKC-δ in opioid-initiated cardioprotection
48. Effects of naloxone on myocardial ischemic preconditioning in humans
49. Attenuation of neutrophil and endothelial activation by intravenous morphine in patients with acute myocardial infarction
50. Role of bradykinin in myocardial preconditioning
51. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts
52. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart
53. Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin
54. Ischemic preconditioning in pigs: A graded phenomenon: Its relation to adenosine and bradykinin
55. Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning
56. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: Implication of bradykinin-dependent and bradykinin-independent mechanisms
57. 2 receptor activation
58. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia-reperfusion injury following 3 and 7 days of reperfusion
59. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty